BeidahuangGGH
BeidahuangGGH
Harbin, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Active, not recruiting | Not stated | 2026-02-04 | NCT07387874 |